Introduction
ONCOGENESIS, MALIGNANCIES
Dysfunctional sphingolipid metabolism is now being recognized as a hallmark of oncogenesis [Multiple pre-clinical studies indicate that targeting sphingolipid metabolism by increasing ceramide levels or inhibiting sphingosine-1-phosphate-mediated cell growth might provide a novel avenue to overcome chemoresistance in advanced malignancies [